ArticleOncoimmunology2021

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect.

Nona Janikashvili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.